J M Graf - JoVE Visualize

Showing results (31-40 of 47) with videos related to

Pageof 5

Sort By:

Medizinische Klinik (Munich, Germany : 1983)|January 21, 2000

[Common effect measures in medical and health economics studies? Results of an exploratory survey of physicians]H H König, C Hoffmann, J M Graf von der Schulenburg, et al.

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 30, 2009

Validating the EQ-5D with time trade off for the German populationW Greiner, C Claes, J J V Busschbach, et al.

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|February 1, 2012

[Implementation of the new German job role code and its application in claims data analysis. Possibilities and limitations]K Damm, A Lange, J Zeidler, et al.

Pharmacoeconomics|December 9, 1993

Economic evaluation of lenograstim (glycosylated rHuG-CSF) in the treatment of inflammatory breast cancer for Germany and ItalyV Mapelli, J M Graf vond der Schulenburg, U Laaser, et al.

European Journal of Medical Research|February 6, 2003

Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAARTM Stoll, C Claes, E Schulte, et al.

MMW Fortschritte Der Medizin|May 26, 2001

[The cost of an HIV patient. Lack of funds for optimal treatment?]M Stoll, E Schulte, C Claes, et al.

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 21, 2017

Guidelines versus reality: is coronary stent application in three-vessel disease standard or the exception?Roland Linder, J Zeidler, F Verheyen, et al.

Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|August 24, 2000

[Deficits in socioeconomic and psychosocial support of HIV-positive women]E Schulte, C Claes, T Körner, et al.

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 5, 2013

[Calculation of disease-related costs in claims data analyses with the example of attention-deficit hyperactivity disorder. Comparison of methods]J Zeidler, A Lange, S Braun, et al.

Zeitschrift Fur Rheumatologie|September 14, 2007

[Current status of ambulatory rheumatologic health care in Germany. Structure of health care and range of services]T Mittendorf, E Edelmann, J Kekow, et al.

Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:

Pageof 5

Medizinische Klinik (Munich, Germany : 1983)|January 21, 2000

[Common effect measures in medical and health economics studies? Results of an exploratory survey of physicians]H H König, C Hoffmann, J M Graf von der Schulenburg, et al.

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 30, 2009

Validating the EQ-5D with time trade off for the German populationW Greiner, C Claes, J J V Busschbach, et al.

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|February 1, 2012

[Implementation of the new German job role code and its application in claims data analysis. Possibilities and limitations]K Damm, A Lange, J Zeidler, et al.

Pharmacoeconomics|December 9, 1993

Economic evaluation of lenograstim (glycosylated rHuG-CSF) in the treatment of inflammatory breast cancer for Germany and ItalyV Mapelli, J M Graf vond der Schulenburg, U Laaser, et al.

European Journal of Medical Research|February 6, 2003

Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAARTM Stoll, C Claes, E Schulte, et al.

MMW Fortschritte Der Medizin|May 26, 2001

[The cost of an HIV patient. Lack of funds for optimal treatment?]M Stoll, E Schulte, C Claes, et al.

The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 21, 2017

Guidelines versus reality: is coronary stent application in three-vessel disease standard or the exception?Roland Linder, J Zeidler, F Verheyen, et al.

Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|August 24, 2000

[Deficits in socioeconomic and psychosocial support of HIV-positive women]E Schulte, C Claes, T Körner, et al.

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 5, 2013

[Calculation of disease-related costs in claims data analyses with the example of attention-deficit hyperactivity disorder. Comparison of methods]J Zeidler, A Lange, S Braun, et al.

Zeitschrift Fur Rheumatologie|September 14, 2007

[Current status of ambulatory rheumatologic health care in Germany. Structure of health care and range of services]T Mittendorf, E Edelmann, J Kekow, et al.

Pageof 5